Your browser doesn't support javascript.
loading
Neuro-Oncology Practice Clinical Debate: long-term antiepileptic drug prophylaxis in patients with glioma.
Stocksdale, Brian; Nagpal, Seema; Hixson, John D; Johnson, Derek R; Rai, Prashant; Shivaprasad, Akhil; Tremont-Lukats, Ivo W.
Afiliação
  • Stocksdale B; Drexel University College of Medicine, Philadelphia, Pennsylvania.
  • Nagpal S; Department of Neurology, Stanford University, California.
  • Hixson JD; Department of Neurology, University of California San Francisco.
  • Johnson DR; Department of Radiology, Mayo Clinic, Rochester, Minnesota.
  • Rai P; Department of Neurology, The University of Texas Medical Branch at Galveston.
  • Shivaprasad A; Stanley H. Appel Department of Neurology, Houston Methodist Hospital, Texas.
  • Tremont-Lukats IW; Kenneth R. Peak Brain and Pituitary Tumor Center, Houston Methodist Hospital, Texas.
Neurooncol Pract ; 7(6): 583-588, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33312673
ABSTRACT
Patients with primary brain tumors often experience seizures, which can be the presenting symptom or occur for the first time at any point along the illness trajectory. In addition to causing morbidity, seizures negatively affect independence and quality of life in other ways, for example, by leading to loss of driving privileges. Long-term therapy with antiepileptic drugs (AEDs) is the standard of care in brain tumor patients with seizures, but the role of prophylactic AEDs in seizure-naive patients remains controversial. In this article, experts in the field discuss the issues of AED efficacy and toxicity, and explain their differing recommendations for routine use of prophylactic AEDs.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article